{"abstract":"The Office of Management and Budget (OMB) published in the Federal Register a request for information (RFI) regarding new and unused (idle) domestic, U.S.-based, and near shore production capabilities for Finished Dose Forms, Active Pharmaceutical Ingredients, and Key Starting Materials associated with the Administration for Strategic Preparedness and Response (ASPR) 86 List of essential medicines. The RFI provided for a 30-day response period which closed on October 26, 2026. OMB has determined that reopening the comment period until November 27, 2026, is appropriate. This action will allow interested parties additional time to prepare information and responses.","action":"Request for information; reopening of response period.","agencies":[{"raw_name":"OFFICE OF MANAGEMENT AND BUDGET","name":"Management and Budget Office","id":280,"url":"https://www.federalregister.gov/agencies/management-and-budget-office","json_url":"https://www.federalregister.gov/api/v1/agencies/280","parent_id":null,"slug":"management-and-budget-office"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/11/02/2026-22328.html","cfr_references":[],"citation":"91 FR 68988","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The response period for the notice published on September 25, 2026 (91 FR 60983), regarding the RFI on Domestic and Near Shore Manufacturing of Essential Medicines on the ASPR 86 List, is reopened. Responses must be received on or before November 27, 2026.","disposition_notes":null,"docket_ids":[],"dockets":[{"supporting_documents":[],"agency_name":"OMB","documents":[{"comment_count":0,"comment_start_date":"2026-11-02","updated_at":"2026-11-02T09:02:09.654-05:00","comment_url":"https://www.regulations.gov/commenton/OMB_FRDOC_0001-0416","allow_late_comments":false,"id":"OMB_FRDOC_0001-0416","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"OMB_FRDOC_0001","title":"Recently Posted OMB Rules and Notices."}],"document_number":"2026-22328","effective_on":null,"end_page":68988,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/11/02/2026-22328.xml","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22328/request-for-information-reopening-of-comment-period","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-22328?publication_date=2026-11-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-11-02/2026-22328/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":110,"last_updated":"2026-11-03 12:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-11-02/pdf/2026-22328.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22328.pdf?1793364316","publication_date":"2026-11-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/11/02/2026-22328.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"OMB","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=OMB_FRDOC_0001","supporting_documents_count":0,"docket_id":"OMB_FRDOC_0001","document_id":"OMB_FRDOC_0001-0416","regulation_id_number":null,"title":"Recently Posted OMB Rules and Notices.","checked_regulationsdotgov_at":"2026-11-03T16:55:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":68988,"subtype":null,"title":"Request for Information; Reopening of Comment Period","toc_doc":"Domestic and Near Shore Manufacturing of Essential Medicines on the Administration for Strategic Preparedness and Response 86 List; Reopening of Comment Period","toc_subject":"Request for Information","topics":[],"type":"Notice","volume":91}